Should I buy Corebridge Financial (CRBG) stock or is it too late?
⭐ The most reliable of them, either direction: Mizuho — 82% of its targets hit on this sector (28 calls tested). It aims for $36 (+10 %), call made on July 10, 2026, maturing on July 10, 2027 (49 d ago).
Firm-by-firm track record on Corebridge Financial
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| Wells Fargo | 62 % | +19.2 % | 16 | $39 +20% |
| Keefe, Bruyette & Woods | 20 % | -0.3 % | 5 | $43 +32% |
| Piper Sandler | 57 % | -1.0 % | 7 | $38 +16% |
| RBC Capital | 89 % | +32.0 % | 9 | — |
✅ Reasons to believe
- 75% of analysts rate it a buy (Buy consensus, 12 ratings) — a sign of market conviction.
- Median price target $38, i.e. +16% from the current price ($33).
- Pays a dividend (3.4% yield) — regular income on top of potential upside.
⚠️ Reasons to hesitate
- Even the most reliable firm on CRBG, UBS (100% hit rate, 4 scored calls), only targets $32 (call made on July 8, 2026, maturing on July 8, 2027) (-2%) in its most recent call, and $33 (call made on January 8, 2026, maturing on January 8, 2027) (+1%) in the one coming due soonest. The stock may already have run past its target.
- The consensus is not unanimous: of 12 ratings, 3 are neutral.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
The analyst consensus on CRBG
Median target $38 (+16%) · 12 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in Corebridge Financial now?
We won't decide for you. The facts: 75% of analysts rate it a buy, median target $38 (+16%), and UBS (most reliable on CRBG, 100%) targets $32. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in Corebridge Financial?
Not according to analysts: the median target ($38) is still +16% above the current price ($33) (most reliable on CRBG: UBS, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is Corebridge Financial still worth investing in?
It depends on the gap between the price ($33) and its estimated value: analysts target $38 on median (+16%), with 75% buys (most reliable on CRBG: UBS, 100%). Cross-check with their real reliability on CRBG and the cautions above. Information, not advice.
What's the main risk in buying CRBG?
Even the most reliable firm on CRBG, UBS (100% hit rate, 4 scored calls), only targets $32 (call made on July 8, 2026, maturing on July 8, 2027) (-2%) in its most recent call, and $33 (call made on January 8, 2026, maturing on January 8, 2027) (+1%) in the one coming due soonest. The stock may already have run past its target.
→ Go deeper: the full Corebridge Financial profile (consensus, analyst reliability, price target, performance).